News
Both the European and Chinese stock markets have outperformed the US since election day, meaning ... vaccines and has a broad portfolio targeting diseases such as shingles, meningitis, and influenza.
Pfizer and BioNTech have teamed up to develop an influenza and Covid-19 combination vaccine that uses mRNA technology, starting multiple clinical trials evaluating updated formulations.
It is caused by influenza viruses ... With rare exceptions, seasonal vaccines are recommended for everyone 6 months and older to avoid illness and to prevent serious complications from flu.
a messenger RNA-based vaccine candidate, to address unmet medical needs for the prevention of disease caused by pandemic influenza A virus H5N1. The FDA's fast-track program is designed to ...
The MMR vaccine is an attenuated vaccine, meaning it uses particles of live viruses to help generate the body's immune response and build antibodies, says Dr. Matthew Harris, a pediatric emergency ...
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1 Arcturus Therapeutics Holdings Inc. (the ...
The counterfeit vaccine is falsely labelled as a product of Indian Immunologicals Limited, a government subsidiary, the drug control body stated. NEW DELHI: The Delhi Drugs Control Department has ...
Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian ...
vaccine candidate, ARCT-2304, designed for active immunization to protect against disease caused by influenza A H5N1 subtype contained in the vaccine. This designation recognizes the potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results